Merck’s Ebola vaccine is approved, which the WHO calls a ‘triumph’
Ervebo has been approved by European drugs regulators to protect against the Zaire strain of the virus, which is the most common
18 October 2019 - 18:17
London — The world’s first Ebola vaccine was recommended for approval by European drugs regulators on Friday in a move hailed by the World Health Organisation (WHO) as a “triumph for public health” that would save many lives.
The vaccine, developed by US drug maker Merck, is already being used under emergency guidelines to try to protect people against the spread of a deadly Ebola outbreak in the Democratic Republic of the Congo (DRC)...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.